Long-term results of minimally invasive transanal surgery for rectal tumors in 249 consecutive patients.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 22 04 2022
accepted: 27 06 2022
pubmed: 13 8 2022
medline: 3 3 2023
entrez: 12 8 2022
Statut: ppublish

Résumé

To delineate the long-term results of minimally invasive transanal surgery (MITAS) for selected rectal tumors. We analyzed data, retrospectively, on consecutive patients who underwent MITAS between 1995 and 2015, to establish the feasibility, excision quality, and perioperative and oncological outcomes of this procedure. MITAS was performed on 243 patients. The final histology included 142 cancers, 47 adenomas, and 52 neuroendocrine tumors (NET G1). A positive margin of 1.6% and 100% en bloc resection were achieved. The mean operative time was 27.4 min. Postoperative morbidity occurred in 7% of patients, with 0% mortality. The median follow-up was 100 months (up to ≥ 5 years or until death in 91.8% of patients). Recurrence developed in 2.9% of the patients. The 10-year overall survival rate was 100% for patients with NET G1 and 80.3% for those with cancer. The 5-year DFS was 100% for patients with Tis cancer, 90.6% for those with T1 cancer, and 87.5% for those with T2 or deeper cancers. MITAS for rectal tumors ≥ 3 cm resulted in perioperative and oncologic outcomes equivalent to those for tumors < 3 cm. MITAS is feasible for the local excision (LE) of selected rectal tumors, including tumors ≥ 3 cm. It reduces operative time and secures excision quality and long-term oncological outcomes.

Identifiants

pubmed: 35962290
doi: 10.1007/s00595-022-02570-z
pii: 10.1007/s00595-022-02570-z
pmc: PMC9950212
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-315

Informations de copyright

© 2022. The Author(s).

Références

Dis Colon Rectum. 1995 Dec;38(12):1286-95
pubmed: 7497841
J Natl Compr Canc Netw. 2018 Jul;16(7):874-901
pubmed: 30006429
Ann Surg. 2009 May;249(5):776-82
pubmed: 19387326
Tech Coloproctol. 2002 Apr;6(1):33-6
pubmed: 12077639
Dis Colon Rectum. 2020 Sep;63(9):1191-1222
pubmed: 33216491
J Clin Oncol. 2013 Dec 1;31(34):4273-5
pubmed: 24166519
Dis Colon Rectum. 2008 Jul;51(7):1026-30; discussion 1030-1
pubmed: 18481147
Surg Endosc. 2020 Apr;34(4):1688-1695
pubmed: 31292744
Tech Coloproctol. 2021 Sep;25(9):997-1010
pubmed: 34173121
Ann Surg. 2018 May;267(5):910-916
pubmed: 28252517
J Anus Rectum Colon. 2019 Oct 30;3(4):175-195
pubmed: 31768468
Dis Colon Rectum. 2000 Aug;43(8):1064-71; discussion 1071-4
pubmed: 10950004
Colorectal Dis. 2011 Jul;13(7):762-7
pubmed: 20345967
Ann Surg. 2002 Oct;236(4):522-29; discussion 529-30
pubmed: 12368681
Ann Surg. 2007 May;245(5):726-33
pubmed: 17457165
Dis Colon Rectum. 2015 Feb;58(2):254-61
pubmed: 25585086
Br J Surg. 2009 Mar;96(3):280-90
pubmed: 19224520
Colorectal Dis. 2009 Mar;11(3):270-5
pubmed: 18573118
Surg Endosc. 2015 Apr;29(4):755-73
pubmed: 25609317
Dis Colon Rectum. 2009 Apr;52(4):577-82
pubmed: 19404055
Surg Today. 2020 Dec;50(12):1652-1656
pubmed: 32617675
Eur J Surg. 1997 Mar;163(3):219-21
pubmed: 9085065
Br J Surg. 1994 Jul;81(7):1057
pubmed: 7922064
Int J Colorectal Dis. 2020 Jul;35(7):1173-1182
pubmed: 32447481
Dis Colon Rectum. 2015 Jan;58(1):122-40
pubmed: 25489704
Acta Oncol. 2019 Aug;58(8):1163-1166
pubmed: 31106636
Arch Surg. 2007 Jul;142(7):649-55; discussion 656
pubmed: 17638803
Int J Clin Oncol. 2020 Jan;25(1):1-42
pubmed: 31203527
J Am Coll Surg. 2004 Sep;199(3):353-60
pubmed: 15325603
J Gastrointest Oncol. 2015 Jun;6(3):296-306
pubmed: 26029457
Colorectal Dis. 2013;15(10):e576-81
pubmed: 24635913
Surg Endosc. 2020 Mar;34(3):1025-1034
pubmed: 31754850
Colorectal Dis. 2013 Aug;15 Suppl 2:1-38
pubmed: 23848492
Gastrointest Endosc. 2010 Dec;72(6):1217-25
pubmed: 21030017
Ann Gastroenterol Surg. 2020 Oct 26;5(1):39-45
pubmed: 33532679
Ann Surg. 2005 Oct;242(4):472-7; discussion 477-9
pubmed: 16192807
Colorectal Dis. 2019 Jan;21(1):15-22
pubmed: 30300969
Colorectal Dis. 2013 Jul;15(7):788-97
pubmed: 23331927
Br J Surg. 2020 Dec;107(13):1719-1730
pubmed: 32936943
Colorectal Dis. 2020 Dec;22(12):2038-2048
pubmed: 32886836
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40
pubmed: 28881920
Dis Colon Rectum. 2005 Jul;48(7):1380-8
pubmed: 15906120
Surg Endosc. 2014 Feb;28(2):427-38
pubmed: 24149849
Acta Oncol. 2009;48(3):343-53
pubmed: 18855161
Surg Endosc. 2013 Sep;27(9):3315-21
pubmed: 23479257

Auteurs

Kotaro Maeda (K)

Department of Surgery, Medical Corporation Kenikukai Shonan Keiiku Hospital, 4360 Endo, Fujisawa, Kanagawa, 252-0816, Japan. kmaeda@keiiku.gr.jp.

Yoshikazu Koide (Y)

Department of Surgery, Fujita Health University Hospital, Toyoake, 470-1192, Japan.

Hidetoshi Katsuno (H)

Department of Surgery, Fujita Health University Okazaki Medical Center, Okazaki, 444-0827, Japan.

Yosuke Tajima (Y)

Department of Surgery, Fujita Health University Hospital, Toyoake, 470-1192, Japan.

Tsunekazu Hanai (T)

Department of Surgery, Fujita Health University Hospital, Toyoake, 470-1192, Japan.

Koji Masumori (K)

Department of Surgery, Fujita Health University Hospital, Toyoake, 470-1192, Japan.

Hiroshi Matsuoka (H)

Department of Surgery, Fujita Health University Hospital, Toyoake, 470-1192, Japan.

Miho Shiota (M)

Department of Surgery, Kaisei Hospital, Sakaide, 657-0068, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH